- Home
- Publications
- Publication Search
- Publication Details
Title
Drug repurposing against COVID-19: focus on anticancer agents
Authors
Keywords
-
Journal
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 39, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-05-12
DOI
10.1186/s13046-020-01590-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
- (2020) Manli Wang et al. CELL RESEARCH
- Repurposing chlorpromazine in the treatment of glioblastoma multiforme: analysis of literature and forthcoming steps
- (2020) Claudia Abbruzzese et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS
- (2020) Yushun Wan et al. JOURNAL OF VIROLOGY
- Anti-HCV, nucleotide inhibitors, repurposing against COVID-19
- (2020) Abdo A. Elfiky LIFE SCIENCES
- Therapeutic options for the 2019 novel coronavirus (2019-nCoV)
- (2020) Guangdi Li et al. NATURE REVIEWS DRUG DISCOVERY
- Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection
- (2020) Emmie de Wit et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
- (2020) Alexandra C. Walls et al. CELL
- Functional exhaustion of antiviral lymphocytes in COVID-19 patients
- (2020) Meijuan Zheng et al. Cellular & Molecular Immunology
- Repurposing of clinically approved drugs for treatment of coronavirus disease 2019 in a 2019-novel coronavirus-related coronavirus model
- (2020) Hua-Hao Fan et al. CHINESE MEDICAL JOURNAL
- Chest CT manifestations of new coronavirus disease 2019 (COVID-19): a pictorial review
- (2020) Zheng Ye et al. EUROPEAN RADIOLOGY
- New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?
- (2020) Christian A. Devaux et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Teicoplanin: an alternative drug for the treatment of COVID-19?
- (2020) Sophie Alexandra Baron et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Aminoquinolines against coronavirus disease 2019 (COVID-19): chloroquine or hydroxychloroquine
- (2020) Zahra Sahraei et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
- (2020) Yeming Wang et al. LANCET
- Caring for patients with cancer in the COVID-19 era
- (2020) Joris van de Haar et al. NATURE MEDICINE
- Audio Interview: New Research on Possible Treatments for Covid-19
- (2020) Eric J. Rubin et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
- (2020) Bin Cao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Compassionate Use of Remdesivir for Patients with Severe Covid-19
- (2020) Jonathan Grein et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effective treatment of severe COVID-19 patients with tocilizumab
- (2020) Xiaoling Xu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors
- (2020) Linlin Zhang et al. SCIENCE
- Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies
- (2020) Jianjun Gao et al. BioScience Trends
- Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2
- (2020) Yadi Zhou et al. Cell Discovery
- Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
- (2020) Mayla Gabriela Silva Borba et al. JAMA Network Open
- Emapalumab: First Global Approval
- (2019) Zaina T. Al-Salama DRUGS
- The kinase inhibitor SI113 induces autophagy and synergizes with quinacrine in hindering the growth of human glioblastoma multiforme cells
- (2019) Silvia Matteoni et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Dose-ranging and cohort-expansion study of monalizumab(IPH2201) in advanced gynecologic malignancies:A trial of the Canadian Cancer Trials Group (CCTG):IND221
- (2019) Anna V Tinker et al. CLINICAL CANCER RESEARCH
- Cellular therapy: Immune‐related complications
- (2019) Joseph H. Oved et al. IMMUNOLOGICAL REVIEWS
- The Use of Ribavirin as an Anticancer Therapeutic: Will It Go Viral?
- (2019) Joshua Casaos et al. MOLECULAR CANCER THERAPEUTICS
- The 1918 influenza pandemic: 100 years of questions answered and unanswered
- (2019) Jeffery K. Taubenberger et al. Science Translational Medicine
- Optimizing pharmacokinetics of intravesical chemotherapy for bladder cancer
- (2019) Gregory A. Joice et al. Nature Reviews Urology
- Lopinavir-Ritonavir Combination Induces Endoplasmic Reticulum Stress and Kills Urological Cancer Cells
- (2019) KAZUKI OKUBO et al. ANTICANCER RESEARCH
- A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics
- (2019) Sabue Mulangu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting mTOR and Metabolism in Cancer: Lessons and Innovations
- (2019) Cedric Magaway et al. Cells
- MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile
- (2018) Waleed H. Mahallawi et al. CYTOKINE
- Deregulation of SGK1 in Ulcerative Colitis: A Paradoxical Relationship Between Immune Cells and Colonic Epithelial Cells
- (2018) Rocco Spagnuolo et al. INFLAMMATORY BOWEL DISEASES
- Cytokine release syndrome
- (2018) Alexander Shimabukuro-Vornhagen et al. Journal for ImmunoTherapy of Cancer
- Comprehending a Killer: The Akt/mTOR Signaling Pathways Are Temporally High-Jacked by the Highly Pathogenic 1918 Influenza Virus
- (2018) Charlene Ranadheera et al. EBioMedicine
- mTOR Cross-Talk in Cancer and Potential for Combination Therapy
- (2018) Fabiana Conciatori et al. Cancers
- Nivolumab-induced cytokine-release syndrome in relapsed/refractory Hodgkin's lymphoma: a case report and literature review
- (2018) Lingdi Zhao et al. Immunotherapy
- Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells
- (2018) Pascale André et al. CELL
- NKG2A, a New Kid on the Immune Checkpoint Block
- (2018) John B. Haanen et al. CELL
- Drug repurposing for the treatment of glioblastoma multiforme
- (2017) Claudia Abbruzzese et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- AMPK: guardian of metabolism and mitochondrial homeostasis
- (2017) Sébastien Herzig et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- The small molecule SI113 synergizes with mitotic spindle poisons in arresting the growth of human glioblastoma multiforme
- (2017) Claudia Abbruzzese et al. Oncotarget
- Bacillus Calmette-Guerin alleviates airway inflammation and remodeling by preventing TGF-β1 induced epithelial–mesenchymal transition
- (2017) Xinrui Tian et al. Human Vaccines & Immunotherapeutics
- Vacinação com BCG e redução do risco de asma
- (2017) Adelmir Souza-Machado et al. Jornal Brasileiro de Pneumologia
- The Warburg effect as an adaptation of cancer cells to rapid fluctuations in energy demand
- (2017) Tamir Epstein et al. PLoS One
- Immunotherapeutic Interleukin-6 or Interleukin-6 Receptor Blockade in Cancer: Challenges and Opportunities
- (2017) Nirmala Chandralega Kampan et al. CURRENT MEDICINAL CHEMISTRY
- Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
- (2016) Daniel J Klionsky et al. Autophagy
- Targeting AMPK Signaling Pathway to Overcome Drug Resistance for Cancer Therapy
- (2016) Zhiyu Wang et al. CURRENT DRUG TARGETS
- Time to use a dose of Chloroquine as an adjuvant to anti-cancer chemotherapies
- (2016) Steve Pascolo EUROPEAN JOURNAL OF PHARMACOLOGY
- Use of an anti-viral drug, Ribavirin, as an anti-glioblastoma therapeutic
- (2016) F Volpin et al. ONCOGENE
- A Single-Arm, Proof-Of-Concept Trial of Lopimune (Lopinavir/Ritonavir) as a Treatment for HPV-Related Pre-Invasive Cervical Disease
- (2016) Lynne Hampson et al. PLoS One
- Metabolic regulation of natural killer cells: Figure 1
- (2015) David K. Finlay BIOCHEMICAL SOCIETY TRANSACTIONS
- Sirolimus is effective in relapsed/refractory autoimmune cytopenias: results of a prospective multi-institutional trial
- (2015) K. L. Bride et al. BLOOD
- SI113, a Specific Inhibitor of the Sgk1 Kinase Activity that Counteracts Cancer Cell Proliferation
- (2015) Lucia D''Antona et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Host cell mTORC1 is required for HCV RNA replication
- (2015) Stefanie Stöhr et al. GUT
- Role of autophagy in the maintenance and function of cancer stem cells
- (2015) Ilio Vitale et al. INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY
- Randomized Phase II Trial of Ridaforolimus in Advanced Endometrial Carcinoma
- (2015) Amit M. Oza et al. JOURNAL OF CLINICAL ONCOLOGY
- Metabolic reprogramming: the emerging concept and associated therapeutic strategies
- (2015) Go J. Yoshida JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- BCG-associated heterologous immunity, a historical perspective: experimental models and immunological mechanisms
- (2015) B. Freyne et al. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
- Preclinical model in HCC: the SGK1 kinase inhibitor SI113 blocks tumor progression in vitro and in vivo and synergizes with radiotherapy
- (2015) Cristina Talarico et al. Oncotarget
- Antiviral Potential of ERK/MAPK and PI3K/AKT/mTOR Signaling Modulation for Middle East Respiratory Syndrome Coronavirus Infection as Identified by Temporal Kinome Analysis
- (2014) Jason Kindrachuk et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Sarilumab, a fully human monoclonal antibody against IL-6Rα in patients with rheumatoid arthritis and an inadequate response to methotrexate: efficacy and safety results from the randomised SARIL-RA-MOBILITY Part A trial
- (2013) Tom W J Huizinga et al. ANNALS OF THE RHEUMATIC DISEASES
- Chloroquine in Cancer Therapy: A Double-Edged Sword of Autophagy
- (2013) T. Kimura et al. CANCER RESEARCH
- Cidofovir: A Novel Antitumor Agent for Glioblastoma
- (2013) P. Hadaczek et al. CLINICAL CANCER RESEARCH
- Adjuvant Treatment With a Mammalian Target of Rapamycin Inhibitor, Sirolimus, and Steroids Improves Outcomes in Patients With Severe H1N1 Pneumonia and Acute Respiratory Failure*
- (2013) Chun-Hua Wang et al. CRITICAL CARE MEDICINE
- Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1
- (2013) Chuan Wu et al. NATURE
- Enhancement of T cell-mediated immune responses to whole inactivated influenza virus by chloroquine treatment in vivo
- (2013) Bruno Garulli et al. VACCINE
- Host mTORC1 Signaling Regulates Andes Virus Replication
- (2012) S. McNulty et al. JOURNAL OF VIROLOGY
- Sgk1 enhances RANBP1 transcript levels and decreases taxol sensitivity in RKO colon carcinoma cells
- (2012) R Amato et al. ONCOGENE
- Different host cell proteases activate the SARS-coronavirus spike-protein for cell–cell and virus–cell fusion
- (2011) Graham Simmons et al. VIROLOGY
- Ribavirin for the treatment of chronic hepatitis C virus infection: a review of the proposed mechanisms of action
- (2011) Jan Paeshuyse et al. Current Opinion in Virology
- mTOR signaling and drug development in cancer
- (2010) Janet Dancey Nature Reviews Clinical Oncology
- TORC-Specific Phosphorylation of Mammalian Target of Rapamycin (mTOR): Phospho-Ser2481 Is a Marker for Intact mTOR Signaling Complex 2
- (2009) J. Copp et al. CANCER RESEARCH
- Sgk1 activates MDM2-dependent p53 degradation and affects cell proliferation, survival, and differentiation
- (2009) Rosario Amato et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Tocilizumab: The first interleukin-6-receptor inhibitor
- (2008) Anthony Sebba AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Inhibition of human coronavirus 229E infection in human epithelial lung cells (L132) by chloroquine: Involvement of p38 MAPK and ERK
- (2007) Masakazu Kono et al. ANTIVIRAL RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More